I am upgrading Thermo Fisher Scientific Inc. to a “Buy” with a fair value of $610 per share due to anticipated recovery in the pharma and biotech industries. Thermo Fisher's high-impact ...

Analyst Daniel Brennan of TD Cowen maintained a Buy rating on Thermo Fisher (TMO – Research Report), boosting the price target to $686.00. Daniel Brennan has given his Buy rating due to a ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended September 28 ...

(Reuters) - Thermo Fisher Scientific on Wednesday raised the lower end of its annual profit forecast, tweaking it for the third time this year, betting on improved demand for its tools and ...

Good morning, ladies and gentlemen, and welcome to the Thermo Fisher Scientific 2024 third quarter conference call. My name is Ezra, and I will be your coordinator today. [Operator instructions] I ...

Boston, USA-headquartered essential equipment and chemicals supplier to pharmaceutical industry Thermo Fisher Scientific is setting up a bioprocess design centre (BDC) at Genome Valley ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...